Comparative Pharmacology
Head-to-head clinical analysis: OBY TRIM versus SANOREX.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OBY TRIM versus SANOREX.
OBY-TRIM vs SANOREX
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
OBY-TRIM is a combination of phentermine, a sympathomimetic amine anorectic that stimulates the hypothalamus to release norepinephrine, suppressing appetite, and a diuretic (often a thiazide) to reduce fluid retention.
Serotonin 5-HT2C receptor agonist; stimulates pro-opiomelanocortin (POMC) neurons, leading to release of α-melanocyte-stimulating hormone (α-MSH) and activation of melanocortin-4 receptors in the hypothalamus, reducing appetite.
Oral: 1 capsule (phentermine 18.75 mg / chlorpheniramine 6.25 mg) twice daily, 30 minutes before meals.
Oral: 1 mg twice daily for 12 weeks; maximum dose: 2 mg/day.
None Documented
None Documented
Terminal half-life is approximately 20–30 hours in adults with normal renal function. This allows for once-daily dosing in most patients.
Terminal elimination half-life: 2-4 hours; context: requires multiple daily dosing to maintain therapeutic effect.
Primarily renal (90% as unchanged drug and metabolites), with about 10% biliary/fecal. In an acidic urine, elimination half-life increases.
Renal: 90% unchanged; biliary/fecal: 10%
Category C
Category C
Anorexiant
Anorexiant